Clinical Trials for Prometheus Laboratories

Explore 6 clinical trials worldwide

Showing 1-6 of 6 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruitingSponsor: Prometheus Laboratories

Clinical Trials (6)

NCT02964078
Interleukin-2 and Pembrolizumab for Metastatic Kidney Cancer
PHASE2Active, not recruiting
27 participants
Started: Apr 25, 2017 · Completed: Oct 31, 2025
1 condition3 sponsors1 location
NCT02340676
A Phase II Trial of Low-Dose Interleukin-2 (IL-2) Added to Extra-Corporeal Photopheresis for Steroid-Refractory cGVHD
PHASE2Active, not recruiting
25 participants
Started: Feb 28, 2015 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT02306954
Study of High Dose Interleukin-2 (IL-2) and Stereotactic Body Radiation (SBRT) in Patients With Metastatic Renal Cancer
PHASE2Active, not recruiting
84 participants
Started: Dec 31, 2014 · Completed: Dec 31, 2026
1 condition3 sponsors1 location
NCT01366092
Daily IL-2 for Steroid-Refractory Chronic Graft-versus-Host-Disease
PHASE2Active, not recruiting
35 participants
Started: Jul 31, 2011 · Completed: Dec 31, 2025
1 condition3 sponsors3 locations
NCT01416831
Comparison of High-dose IL-2 and High-dose IL-2 With Radiation Therapy in Patients With Metastatic Melanoma.
PHASE2Active, not recruiting
44 participants
Started: Jul 1, 2011 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT00338377
Lymphodepletion Plus Adoptive Cell Transfer With or Without Dendritic Cell Immunization in Patients With Metastatic Melanoma
PHASE2Active, not recruiting
1,230 participants
Started: Feb 1, 2006 · Completed: Feb 28, 2030
1 condition5 sponsors1 location